Search

everythinglearnresearchcommunity

for

Search:↓

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Both treatments for localized alopecia areata are equally effective.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

The 308-nm Excimer laser is effective and safe for treating patchy alopecia areata in children.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Non-immune factors play a significant role in alopecia areata.

People with alopecia areata have higher insulin resistance.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Certain gene variations may increase the risk and severity of alopecia areata.

Oral vitamin D treatment can help some children with alopecia areata who have vitamin D deficiency.

People with alopecia areata often have lower vitamin D levels than healthy people.